Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, August 04, 2022
Evonik is building a new cGMP facility to manufacture lipids for clinical development and launch of innovative medicines. The new cGMP lipid launch facility is located in Hanau, Germany and will provide customers with smaller batch sizes of lipids as...
read more
Thursday, August 04, 2022
LifeNet Health LifeSciences, a leader in all-human biomedical research solutions, is launching a new Cell-Based Assay Service following the acquisition of biotechnology firm IONTOX.
read more
Thursday, August 04, 2022
Curia has appointed Niall Condon as president of its Manufacturing Division. Condon will drive growth and be responsible for operations of Curia’s commercial manufacturing services and products, including API and Drug Product.
read more
TetraScience has joined forces with ACD/Labs, a provider of scientific R&D software, to help pharma and biopharma customers achieve greater scientific insights.
read more
Azenta opened its new China headquarters in Suzhou, which serves as the hub for operations in the Asia Pacific.
read more
For patients, the new Digital Front Door software unlocks interoperability, patient access, data sharing, simplified informed consent process and boosted participant engagement. This leads to better patient retention and a lighter caregiver burden ...
read more
Samsung Biologics, a leading contract development and manufacturing organization, announced strong financial results for the second quarter of 2022.
read more
GreenLight Biosciences and Samsung Bio announced the successful completion of their first commercial-scale mRNA engineering run.
read more
Inotiv announced an expanded capacity to conduct Good Laboratory Practices (“GLP”) studies for in vitro cytogenetics and bacterial mutation assays as components of the Standard Battery of genetic toxicology studies required for first-in-human ...
read more
Soleo Health is now a limited distribution partner for the cardiovascular drug LEQVIO®, manufactured by Novartis.
read more
The Novasep-PharmaZell Group has announced a €7.3M investment for its Mourenx site (southwestern France), as part of a larger project supported by the "France Relance" Plan, to create a multipurpose pilot workshop within one of its production units.
read more
Societal CDMO was selected to support the clinical development of a new drug in Europe.
read more
Worldwide Clinical Trials extends its service offerings to include large molecule capacity. Capabilities include pharmacodynamic studies, pharmacokinetics, biomarker assays, and immunogenicity testing, which will aid research efforts in a variety of ...
read more
CoreRx, Inc. announced the appointment of Dan Dobry as Chief Strategy Officer and a member of CoreRx’s Executive Leadership Team. Dan will report to CoreRx’s Chief Executive Officer, Ajay Damani.
read more
WuXi STA, a subsidiary of WuXi AppTec, has opened a new continuous manufacturing (flow chemistry) plant at its Changzhou campus in China for large-scale active pharmaceutical ingredient (API) and advanced intermediate production.
read more